Beta Bionics, Inc. (BBNX)
NASDAQ: BBNX · Real-Time Price · USD
13.08
-0.16 (-1.21%)
At close: Feb 6, 2026, 4:00 PM EST
13.24
+0.16 (1.22%)
After-hours: Feb 6, 2026, 7:50 PM EST
Beta Bionics Stock Forecast
Stock Price Forecast
The 12 analysts that cover Beta Bionics stock have a consensus rating of "Strong Buy" and an average price target of $27.58, which forecasts a 110.86% increase in the stock price over the next year. The lowest target is $17 and the highest is $40.
Price Target: $27.58 (+110.86%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Beta Bionics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 7 | 7 | 7 | 7 | 7 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 2 | 1 | 1 | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 11 | 11 | 11 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Maintains $31 → $25 | Strong Buy | Maintains | $31 → $25 | +91.13% | Feb 4, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $37 → $25 | Strong Buy | Maintains | $37 → $25 | +91.13% | Feb 2, 2026 |
| TD Cowen | TD Cowen | Hold Initiates $17 | Hold | Initiates | $17 | +29.97% | Jan 27, 2026 |
| Lake Street | Lake Street | Strong Buy Maintains $35 → $40 | Strong Buy | Maintains | $35 → $40 | +205.81% | Jan 9, 2026 |
| B of A Securities | B of A Securities | Strong Buy Maintains $30 → $33 | Strong Buy | Maintains | $30 → $33 | +152.29% | Jan 5, 2026 |
Financial Forecast
Revenue This Year
100.21M
from 65.12M
Increased by 53.88%
Revenue Next Year
135.14M
from 100.21M
Increased by 34.86%
EPS This Year
-1.97
from -8.60
EPS Next Year
-1.81
from -1.97
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 105.1M | 151.2M | ||||
| Avg | 100.2M | 135.1M | ||||
| Low | 94.7M | 121.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 61.4% | 50.9% | ||||
| Avg | 53.9% | 34.9% | ||||
| Low | 45.4% | 21.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -1.91 | -1.33 | ||
| Avg | -1.97 | -1.81 | ||
| Low | -2.02 | -2.28 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | ||
| Avg | - | - | ||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.